The newsletter from the central resource for the Swiss biotech industry
October 2026
Leading global innovation for the 16th consecutive year
Switzerland tops global innovation ranking
Switzerland ranks first in the Global Innovation Index 2026. The report highlights its strong deep tech ecosystem, including one of the highest numbers of venture-backed deep tech companies per capita. Key challenges remain in scaling start-ups, securing later-stage financing, translating research into commercial success and creating globally leading companies. The report recommends stronger technology transfer, shared infrastructure and improved access to capital.
Put your company in the spotlight in 2027
Two ways to boost your visibility
Advertise in the Swiss Biotech Directory: Promote your company in the 2027 print edition of Switzerland's leading biotech compendium, featuring more than 1,700 companies. Secure your advertising space by December 31, 2026. Members receive a discount.
Logo presence for members: Showcase your company logo in Swiss Biotech Association communication materials throughout 2027 for just CHF 200. Book your logo presence by year-end.
Exchange ideas with biotech leaders
Connect and discuss the topics shaping biotech today
Registration deadlines are approaching fast for the CFO and HR leaders meetings, while early registration is open for the CEO meeting in January.
October 19, Olten – Swiss biotech CFO meeting Explore AI in fundraising, partnering, and finance, followed by selected real-world financing and transaction cases from the Swiss biotech ecosystem. Expert input, discussions, and networking provide opportunities to share experience. Register by Oct 16
November 3, Biel – Swiss biotech HR leaders meeting Discuss how transformation and AI are reshaping people, organizations, and culture. Keynotes, panel discussions, interactive workshops, and best-practice exchange address current challenges for HR leaders in biotech. Register by Oct 30
January 29, Zürich – Swiss biotech CEO meeting A platform for informal exchange among Swiss R&D biotech leaders, with more than 200 CEOs registered last year. The meeting fosters connections, provides insights into recent deals and financing rounds, and gathers input to shape the Swiss Biotech Day 2027 on April 26-27. Register early to save your spot.
Predictable regulatory pathways: A key strength of Swiss biotech
Regulatory excellence built on trust
Regulatory excellence is built on talent, collaboration and trust. As science and geopolitics evolve rapidly, Swissmedic acts as a bridge between innovators and regulators, research and safe application, and global standards and Swiss expectations. Cross-disciplinary expertise, evidence-driven decisions, international exchange and tenacity create predictable, credible regulatory pathways that help innovation move securely from development to patients. Read the full article by Jörg Schläpfer, Swissmedic, in the Swiss Biotech Report.
Swiss thriller series showcases biotechnology in action
Toxic: Biotechnology meets suspense
The Swiss thriller series Toxic offers an entertaining and suspenseful glimpse into biotechnology. When a mysterious contamination turns Lake Geneva into a danger zone, a toxicologist investigates an unknown virus while uncovering a potential environmental disaster. The six-part series combines scientific investigation, personal drama and suspense. Available to stream free on Play Suisse in French, German and Italian.
The Swiss Biotech Association partners with several organizations to provide a perfect mix of education and long-term professional development with discount for our members.
Sharing industry perspectives on FDA complete response letters, common pitfalls and practical approaches to building stronger submissions.
Oct 22
From data to discovery Explore how visualization, automation and AI help scientists and engineers analyze data and streamline workflows.
Oct 27
A new approach to in vitro simulation Learn how bioreactor technology enables controlled, reproducible studies of human digestion and gut microbiota.
Oct 27
Building strategic partnerships Practical guidance on selecting and managing external partners to improve flexibility, timelines and supply continuity.
Turning potential into viable product concepts by aligning development with market needs, regulatory requirements, funding and commercialization.
Nov 5 - Dec 10
Good manufacturing practice A four-part course covering standards, technology transfer, quality control and batch release through practical exercises and a facility visit.
You are receiving this email because you were in contact with us or have subscribed to our newsletter. You can unsubscribe any time, but be aware that you will not receive any more info from us.
